38 results
Page 2 of 2
8-K
EX-10.1
hfypx05o v68fop8
13 Jun 16
ContraVir Completes Merger with Ciclofilin Pharmaceuticals
12:00am
8-K
EX-10.1
qqep1vwjf1g psws
31 May 16
ContraVir to Expand Hepatitis B Portfolio through Strategic Merger Agreement with Ciclofilin Pharmaceuticals
12:00am
8-K
EX-10.1
7httxp pqmlww
31 Mar 16
ContraVir Pharmaceuticals Appoints John Cavan as Chief Financial Officer
12:00am
S-8
EX-10.1
7rzfv6e dyhnih8lxir
4 May 15
Registration of securities for employees
12:00am
8-K
EX-10.1
xyiijf06 7kccv
15 Jan 15
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
12:00am
8-K
EX-10.1
bm5vqkmvb44y95
15 Oct 14
ContraVir Pharmaceuticals Closes $9.0 Million Financing to Advance Lead Shingles Candidate
12:00am
8-K
EX-10.1
mcv9me9
26 Jun 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
jugpb4
20 Mar 14
ContraVir Appoints James Sapirstein as Chief Executive Officer and Board Member
12:00am
8-K
EX-10.1
2plu2m2a 3yz
5 Feb 14
Entry into a Material Definitive Agreement
12:00am
10-12G/A
EX-10.7
1om3pp sxo7btb
24 Dec 13
Registration of securities (amended)
12:00am
10-12G/A
EX-10.5
bfiklb62yn8d3pu8
21 Nov 13
Registration of securities (amended)
12:00am
10-12G/A
EX-10.4
9r5q6gwoujz9a3xjmov
21 Nov 13
Registration of securities (amended)
12:00am
10-Q
EX-10.1
5dbidg08u8yactms
19 Nov 13
Quarterly report
12:00am
10-12G/A
EX-10.4
innjk9a26 gt3bzi
20 Sep 13
Registration of securities (amended)
12:00am
10-12G
EX-10.1
mgnja
8 Aug 13
Registration of securities
12:00am
10-12G
EX-10.2
5gc9n9fg
8 Aug 13
Registration of securities
12:00am
10-12G
EX-10.3
r4b 0gu5fp
8 Aug 13
Registration of securities
12:00am